13 Chronic Kidney Disease Clinical Trials in New York, NY (2026)

Q: How do I join a clinical trial in New York?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you.

Recruiting Chronic Kidney Disease Studies in New York

NCT04802395Recruiting

Real World Evidence Clinical Utility Study of KidneyIntelX

The purpose of this study is to assess the impact of the KidneyIntelX assay utilized as part of the current standard of care on the management of patients seen in the primary care physician's office a...

New York, NY10,000 participantsRenalytix AI, Inc.

View Study Details

NCT04334707Recruiting

Kidney Precision Medicine Project

Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despit...

New York, NY1,000 participantsIcahn School of Medicine at Mount Sinai

View Study Details

NCT05465044Recruiting

Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)

In this pragmatic clinical trial, which will dovetail with Veterans' routine outpatient dialysis clinic visits in six VA medical centers, the investigators will study 252 Veterans with kidney disease ...

New York, NYNA252 participantsVA Office of Research and Development

View Study Details

NCT04741646Recruiting

Ferric Citrate and Chronic Kidney Disease in Children

We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in...

New York, NYPHASE2160 participantsUniversity of California, Los Angeles

View Study Details

NCT04671771Recruiting

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

The goal of the CSP-2002 clinical trial is to evaluate the safety and effectiveness of the InnAVasc Arteriovenous Graft (IG) for hemodialysis (HD) access in patients with end-stage renal disease (ESRD...

New York, NYNA133 participantsW.L.Gore & Associates

View Study Details

NCT05786443Recruiting

Safety and Efficacy of Empagliflozin in Hemodialysis

A 12-week, phase II, randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability, and preliminary efficacy of empagliflozin versus placebo among patients initia...

New York, NYPHASE260 participantsNYU Langone Health

View Study Details

NCT03633708Recruiting

A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis...

New York, NYPHASE356 participantsAmgen

View Study Details

NCT07224763Recruiting

Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD

The purpose of this study is to evaluate the safety and efficacy of the GGTA1 KO Thymokidney in patients with end-stage renal disease (ESRD) who are either not eligible for conventional allogeneic kid...

New York, NYPHASE150 participantsUnited Therapeutics

View Study Details

NCT06878560Recruiting

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

The purpose of this study is to evaluate the safety and efficacy of the 10 GE Xenokidney in patients with ESRD who are either not eligible for conventional allogeneic kidney transplantation (Group 1) ...

New York, NYPHASE150 participantsUnited Therapeutics

View Study Details

NCT03991169Recruiting

Oral Iron in Children With Chronic Kidney Disease

This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. n...

New York, NYPHASE440 participantsWeill Medical College of Cornell University

View Study Details

NCT06927024Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)

30 patients will participate in a prospective randomized clinical trial to test the safety, tolerability and efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) for autonomic nervous ...

New York, NYNA30 participantsNYU Langone Health

View Study Details

NCT05981183Recruiting

Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney di...

New York, NYNA20 participantsNYU Langone Health

View Study Details

NCT05106387Recruiting

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study...

New York, NY20 participantsRegeneron Pharmaceuticals

View Study Details

About Chronic Kidney Disease Clinical Trials in New York

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 13 chronic kidney disease clinical trials recruiting participants in New York, NY. These studies are seeking a combined 11,871 participants. Research is being sponsored by Renalytix AI, Inc., Icahn School of Medicine at Mount Sinai, VA Office of Research and Development and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in New York — FAQ

Are there chronic kidney disease clinical trials in New York?

Yes, there are 13 chronic kidney disease clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New York?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.

Are clinical trials in New York free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 13 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated July 19, 2026 from ClinicalTrials.gov